Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

1 result

  • Active substance : acide folique
  • Active substance : bismuth
  • Active substance : docusate de sodium
  • Active substance : gonadotrophine chorionique
  • Active substance : zidovudine
  • Active substance : zinc
  • Topics : Diseases and conditions
Filter
Topic
  • Diseases and conditions (1)
  • Plus ...
    • Pregnancy and reproduction (1)
    • Plus ...
      • Pregnancy (1)
  • Quality of care and patient safety (1)
  • Plus ...
    • Patient information, patients’ rights, patients’ records (1)
    • Plus ...
      • Patient information and patients’ rights (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Language
  • Français (1)
Active substance
  • acide folique (1)
  • alcool (1)
  • aluminium (1)
  • amoxicilline (1)
  • armoise (1)
  • aspirine (1)
  • bisacodyl (1)
  • bismuth (1)
  • clindamycine (1)
  • diosmine (1)
  • docusate de sodium (1)
  • fer (1)
  • fibronectine (1)
  • gonadotrophine chorionique (1)
  • iode (1)
  • lactulose (1)
  • nicotine (1)
  • oxyde de zinc (1)
  • phosphore (1)
  • potassium (1)
  • pyridoxine (1)
  • zidovudine (1)
  • zinc (1)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Improving information provision for pregnant women

    Practice guidelines - Posted on 1/4/2005 - Mis à jour le 9/11/2006
    Download abstract
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
wfJnkYr3TgehtRuB